Goodwin Procter LLP
Continuous administration of L-dopa, dopa decarboxylase inhibitors, catechol-O-methyl transferase inhibitors and compositions for same
Provided herein, in part, is a method of treating a neurological or movement disorder in a patient in need thereof, comprising subcutaneously administering to said patient a pharmaceutically acceptable composition comprising levodopa and optionally carbidopa and optionally entacapone or tolcapone, or pharmaceutically acceptable salts thereof, wherein said composition is administered substantially continuously, and compositions that can be used in the disclosed methods.
NeuroDerm, Ltd.
A A A A A A A A A A A A A A A A A A A A
A61K A61K A61K A61K A61K A61K A61K A61P A61K A61K A61P A61K A61P A61P A61K A61P A61K A61K A61K A61K
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Oron Mara
Yacoby-Zeevi Nemas